JOHN K CLARKE Insider Trading $ALNY ALNYLAM PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN K CLARKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN K CLARKE. JOHN K CLARKE is Director in CUBIST PHARMACEUTICALS INC ($CBST) and Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and Director in aTYR PHARMA INC ($LIFE).
JOHN K CLARKE in ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN K CLARKE: Director
Holdings: 23,891 shares
Current Value: $966,630
Latest Transaction: Jun 22 2018
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN K CLARKE in ALNYLAM PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, LIFE, CBST, MNTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 27.28 | 15,000 | 409,200 | 0 | |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 101.97 | 100 | 10,197 | 8,891 | 9 K to 8.9 K (-1.11 %) |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 101.37 | 2,100 | 212,877 | 8,991 | 11.1 K to 9 K (-18.93 %) |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 100.33 | 10,042 | 1,007,514 | 11,091 | 21.1 K to 11.1 K (-47.52 %) |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 99.38 | 2,758 | 274,090 | 21,133 | 23.9 K to 21.1 K (-11.54 %) |
| Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 27.28 | 15,000 | 409,200 | 23,891 | 8.9 K to 23.9 K (+168.71 %) |
| Jun 06 2017 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 71.99 | 11,250 | 809,888 | 11,250 | |
| Jun 07 2016 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 70.20 | 11,250 | 789,750 | 11,250 | |
| Jun 03 2015 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 131.21 | 11,250 | 1,476,113 | 11,250 |
Page: 1